Literature DB >> 19128956

The abdominoperineal resection itself is associated with an adverse outcome: the European experience based on a pooled analysis of five European randomised clinical trials on rectal cancer.

Marcel den Dulk1, Hein Putter2, Laurence Collette3, Corrie A M Marijnen4, Joakim Folkesson5, Jean-Francois Bosset6, Claus Rödel7, Krzysztof Bujko8, Lars Påhlman5, Cornelis J H van de Velde9.   

Abstract

PURPOSE: The aim of this study is to identify factors associated with the decision to perform an abdominoperineal resection (APR) and to assess if these factors or the surgical procedure itself is associated with circumferential resection margin (CRM) involvement, local recurrence (LR), overall survival (OS) and cancer-specific survival (CSS). PATIENTS AND METHODS: The Swedish Rectal Cancer Trial (SRCT), TME trial, CAO/ARO/AIO-94 trial, EORTC 22921 trial and Polish Rectal Cancer Trial (PRCT) were pooled. A propensity score was calculated, which indicated the predicted probability of undergoing an APR given gender, age and distance, and used in the multivariate analyses.
RESULTS: An APR procedure was associated with an increased risk of CRM involvement [odd ratio (OR) 2.52, p<0.001], increased LR rate [hazard ratio (HR) 1.53, p=0.001] and decreased CSS rate (HR 1.31, p=0.002), whereas the propensity score was not.
CONCLUSION: The results suggest that the APR procedure itself is a significant predictor for non-radical resections and increased risk of LR and death due to cancer for patients with advanced rectal cancer.

Entities:  

Mesh:

Year:  2009        PMID: 19128956     DOI: 10.1016/j.ejca.2008.11.039

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  53 in total

1.  Therapeutic results of abdominoperineal resection in the prone jackknife position for T3-4 low rectal cancers.

Authors:  Xiang Hu; Liang Cao; Jian Zhang; Pin Liang; Ge Liu
Journal:  J Gastrointest Surg       Date:  2014-11-04       Impact factor: 3.452

2.  Laparoscopic extralevator abdominal perineal excision of the rectum: the best of both worlds.

Authors:  B Singh; G Lloyd; P J Nilsson; S Chaudhri
Journal:  Tech Coloproctol       Date:  2011-12-15       Impact factor: 3.781

Review 3.  Update on the surgical pathology standards on rectal cancer diagnosis, staging and quality assessment of surgery.

Authors:  Alejandro Rojo; Pilar Sancho; Oscar Alonso; Sara Encinas; Gemma Toledo; Juan F García
Journal:  Clin Transl Oncol       Date:  2010-06       Impact factor: 3.405

Review 4.  What can we learn from oncology surgical trials?

Authors:  Serge Evrard; Pippa McKelvie-Sebileau; Cornelis van de Velde; Bernard Nordlinger; Graeme Poston
Journal:  Nat Rev Clin Oncol       Date:  2015-10-20       Impact factor: 66.675

5.  Extralevator abdominoperineal excision versus conventional surgery for low rectal cancer: a single surgeon experience.

Authors:  Gürel Neşşar; Ali Eba Demirbağ; Bahadır Celep; Orhan Hayri Elbir; Cüneyt Kayaalp
Journal:  Ulus Cerrahi Derg       Date:  2016-12-01

6.  Oncological superiority of extralevator abdominoperineal resection over conventional abdominoperineal resection: a meta-analysis.

Authors:  Ao Huang; Hongchao Zhao; Tianlong Ling; Yingjun Quan; Minhua Zheng; Bo Feng
Journal:  Int J Colorectal Dis       Date:  2014-01-03       Impact factor: 2.571

7.  Long-term outcome of extralevator abdominoperineal excision (ELAPE) for low rectal cancer.

Authors:  Sigmar Stelzner; Gunter Hellmich; Anja Sims; Thomas Kittner; Eric Puffer; Joerg Zimmer; Dorothea Bleyl; Helmut Witzigmann
Journal:  Int J Colorectal Dis       Date:  2016-09-09       Impact factor: 2.571

Review 8.  Abdominoperineal Excision: Technical Challenges in Optimal Surgical and Oncological Outcomes after Abdominoperineal Excision for Rectal Cancer.

Authors:  Torbjörn Holm
Journal:  Clin Colon Rectal Surg       Date:  2017-11-27

9.  Laparoscopic translevator approach to abdominoperineal resection for rectal adenocarcinoma: feasibility and short-term oncologic outcomes.

Authors:  Vanessa N Palter; Steven MacLellan; Shady Ashamalla
Journal:  Surg Endosc       Date:  2015-10-20       Impact factor: 4.584

10.  Adjuvant chemoradiotherapy of advanced resectable rectal cancer: results of a randomised trial comparing modulation of 5-fluorouracil with folinic acid or with interferon-α.

Authors:  M Kornmann; L Staib; T Wiegel; E-D Kreuser; M Kron; W Baumann; D Henne-Bruns; K-H Link
Journal:  Br J Cancer       Date:  2010-09-28       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.